TipRanks
Go Ultimate55% OFF

Kalaris Therapeutics (KLRS) Balance Sheet

Kalaris Therapeutics Balance Sheet

Kalaris Therapeutics's total assets for Q2 2026 were $99.54M, a decrease of 9.35% from the previous quarter. KLRS total liabilities were $41.87M for the fiscal quarter, a 1.50% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 121.74M$ 118.55M$ 3.33M$ 3.90M$ 286.59M
$ 42.92M$ 5.24M$ 48.35M$ 34.17M$ 61.33M
$ 78.81M$ 113.31M$ -45.02M$ -30.27M$ 225.27M

Currency in USD

Kalaris Therapeutics Debt to Assets

0150M300M450M0 %600 %1200 %1800 %LiabilitiesDebt to Assets20182019202020212022202320242025AssetsLiabilitiesDebt to Assets